03/18/2024
7:35 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
7:30 PM | Atossa Therapeutics (Issuer)
Cigler Tessa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2024
7:35 PM | Atossa Therapeutics (Issuer)
Cigler Tessa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:30 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
3:05 PM | Atossa Therapeutics (Issuer)
Finn Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
8:10 AM | Atossa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
8:00 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
8:00 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:28 PM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:30 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:35 AM | Atossa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/13/2023
3:20 PM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
8:01 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
8:00 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
7:15 PM | Atossa Therapeutics (Issuer)
WEAVER GREGORY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:00 AM | Atossa Therapeutics (Issuer)
WEAVER GREGORY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:15 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
8:10 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
8:15 AM | Atossa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
6:35 PM | Atossa Therapeutics (Issuer)
Galli Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
6:35 PM | Atossa Therapeutics (Issuer)
Chen Shu-Chih (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
6:35 PM | Atossa Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
6:36 PM | Atossa Therapeutics (Issuer)
Remmel H. Lawrence (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
6:36 PM | Atossa Therapeutics (Issuer)
WEAVER GREGORY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
